The early-stage startup, called Spartina Biotechnologies, uses what are called exosomes to deliver genetic material and proteins to cells in the body. This helps to combat infection. Spartina Biotechnologies’ technology packages RNA, a type of genetic molecule, into exosomes. Those exosomes are modified to bind to and deliver the RNA to certain cells, inhibiting viruses in those cells from reproducing.
“This…
Source: The Business Journal